Earnings Feed
Start Free
Home/Filings/4/0001179110-11-012026
4//SEC Filing

Smith Scott E 4

Accession 0001179110-11-012026

CIK 0001222244other
View on SEC.govCompany Profile

Filed

Aug 10, 8:00 PM ET

Accepted

Aug 11, 9:49 AM ET

Size

18.7 KB

Accession

0001179110-11-012026

Insider Transaction Report

Form 4
Period: 2011-08-09
ProUroCare Medical Inc.PUMD
Smith Scott E
Director
Transactions
  • Award

    Stock options

    2011-08-09+28,736→ 28,736 total
    Exercise: $0.87Exp: 2018-08-09→ Common stock, $0.00001 par value (28,736 underlying)
Holdings

  • Warrants

    Exercise: $1.30Exp: 2014-01-07→ Common stock, $0.00001 par value (10,000 underlying)
    10,000

  • Common Stock, $0.00001 par value

    148,883

  • Stock Options

    Exercise: $1.00Exp: 2015-08-12→ Common stock, $0.00001 par value (1,000 underlying)
    1,000

  • Stock options

    Exercise: $1.50Exp: 2016-09-29→ Common stock, $0.00001 par value (30,000 underlying)
    30,000

  • Warrants

    Exercise: $1.30Exp: 2013-07-12→ Common stock, $0.00001 par value (32,475 underlying)
    32,475

  • Options

    Exercise: $1.72Exp: 2017-08-10→ Common stock $0.00001 par value (14,535 underlying)
    14,535

  • Stock Options

    Exercise: $7.00Exp: 2013-05-30→ Common Stock, $0.00001 par value (3,000 underlying)
    3,000

  • Warrants

    Exercise: $0.70Exp: 2012-12-31→ Common Stock, $0.00001 par value (7,000 underlying)
    7,000

  • Stock Options

    Exercise: $0.85Exp: 2016-03-03→ Common stock, $0.00001 par value (20,000 underlying)
    20,000

  • Stock Options

    Exercise: $1.25Exp: 2016-08-11→ Common Stock, $0.00001 par value (1,000 underlying)
    1,000

  • Warrants

    Exercise: $1.30From: 2009-11-12Exp: 2012-11-12→ Common stock, $0.00001 par value (20,000 underlying)
    20,000
Footnotes (3)
  • [F1]Currently exercisable.
  • [F2]Options shall vest on the latter of the date that the Company is cleared by the FDA to sell the ProUroScan System in the United States or the date the Company closes on an aggregate of $2,000,000 or more of incremental equity financing after the date of grant(including the exercise of existing warrants).
  • [F3]Annual option award pursuant to the Issuer's compensation policy for Directors upon their re-election to the Board of Directors at its annual shareholders' meeting. The seven-year options vest ratably over 24 months.

Documents

1 file

Issuer

ProUroCare Medical Inc.

CIK 0001222244

→
Entity typeother

Related Parties

1
  • filerCIK 0001364107

Filing Metadata

Form type
4
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 9:49 AM ET
Size
18.7 KB
View on SEC.gov